Llwytho...
Evidence-based medicine and Management of Hepatocellular Carcinoma in Thalassemia
BACKGROUND: Hepatocellular carcinoma as a complication is linked to improved outcomes of thalassemia. MAIN BODY: Published data suggest an incidence of HCC in thalassemia of about 2%. However, since thalassemia is endemic in many under-developed countries where patients have not probably been screen...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | BMC Gastroenterol |
|---|---|
| Prif Awdur: | |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BioMed Central
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7724702/ https://ncbi.nlm.nih.gov/pubmed/33297979 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12876-020-01542-2 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|